Lung development - The effects of chronic hypoxia

Seminars in Neonatology

Volumn 8, Issue 1, 2003, Pages 1-8

  Haworth, Sheila G ^a   Hislop, Alison A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alveolar development; Bronchial smooth muscle; Endothelin; Nitric oxide; Postnatal adaptation; Pulmonary circulation

Indexed keywords

ADAPTATION; CHRONIC LUNG DISEASE; COR PULMONALE; FETUS; HUMAN; HYPOXIA; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FIBROSIS; LUNG STRUCTURE; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; OXYGEN SUPPLY; POSTNATAL DEVELOPMENT; PREMATURITY; PRENATAL DEVELOPMENT; REVIEW; RISK FACTOR;

EID: 0037301134     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(02)00195-1     Document Type: Review

References (49)

1. Hislop A, Wigglesworth JS, Desai R, Aber V. The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev 1987;15:147-64.
2. Minoo P. Transcriptional regulation of lung development: emergence of specificity. Respir Res 2000;1:109-15 (Review).
3. Warburton D, Zhao J, Berberich MA, Bernfield M. Molecular embryology of the lung: then, now, and in the future. Am J Physiol 1999;276:L697-704.
4. Cardoso WV. Molecular regulation of lung development. Annu Rev Physiol 2001;63:471-94.
5. Shannon JM, Deterding RR. Epithelial-mesenchymal interactions in lung development, In: McDonald JA, editor. Lung growth and development, Marcel Dekker: New York 1997;81-118.
6. Hall SM, Hislop AA, Pierce C, Haworth SG. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation, Am J Respir Cell Mol Biol 2000;23:194-203.
7. Hall SM, Hislop AA, Haworth SG. Origin, differentiation and maturation of human pulmonary veins. Am J Respir Cell Mol Biol 2002;26:333-40.
8. McCray PB. Spontaneous contractility of human fetal airway smooth muscle. Am J Respir Cell Mol Biol 1993;8:573-80.
9. Richards IS, Kulkarni A, Brooks SM. Human fetal tracheal smooth muscle produces spontaneous electromechanical oscillations that are calcium dependent and cholinergically potentiated. Dev Pharmacol Ther 1991;16:22-8.
10. Sparrow MP, Weichselbaum M, McCray PB. Development of the innervation and airway smooth muscle in human fetal lung. Am J Respir Cell Mol Biol 1999;20:550-60.
11. Hislop A, Wigglesworth JS, Desai R. Alveolar development in the human fetus and infant. Early Hum Dev 1986;13:1-11.
12. Thurlbeck WM. Postnatal human lung growth. Thorax 1982;37:564-71.
13. Haworth SG. Pathobiology of pulmonary hypertension in infants and children. Prog Pediatr Cardiol 2001;12:249-69.
14. Hall SM, Gorenflo M, Reader J, Lawson D, Haworth SG. Neonatal pulmonary hypertension prevents reorganisation of the pulmonary arterial smooth muscle cytoskeleton after birth. J Anat 2000;196:391-403.
15. Hislop AA, Springall DR, Oliveira H, Pollock JS, Polak JM, Haworth SG. Endothelial nitric oxide synthase in hypoxic newborn porcine pulmonary vessels. Arch Dis Child 1997;76:F16-22.
16. Arrigoni FI, Hislop AA, Pollock JS, Haworth SG, Mitchell JA. Birth upregulates nitric oxide synthase activity in the porcine lung. Life Sci 2002;70:1609-20.
17. Boels PJ, Deutsch J, Gao B, Haworth SG. Maturation of the response to bradykinin in resistance and conduit pulmonary arteries. Cardiovasc Res 1999;44:416-28.
18. Hislop AA, Haworth SG. Airway size and structure in the normal fetal and infant lung and the effect of premature delivery and artificial ventilation. Am Rev Respir Dis 1989;140:1717-26.
19. Hislop AA, Wharton J, Allen KM, Polak J, Haworth SG. Immunohistochemical localisation of peptice-containing nerves in the airways of normal young children. Am J Respir Cell Mol Biol 1990;3:191-8.
20. Rudolf AM. Hypoxia: historical perspective and unresolved issues. In: Haddad GG, Lister G, editors. Tissue oxygen deprivation: from molecular to integrated function, New York: Marcel Dekker 1996;1-24.
21. Massaro D, Massaro GD. Pulmonary alveoli: formation, the 'call for oxygen', and other regulators. Am J Physiol 2002;282:L345-58.
22. Giles BL, Suliman H, Mamo LB, Piantadosi CA, Oury TD, Nozik-Grayck E. Prenatal hypoxia decreases lung extracellular superoxide dismutase expression and activity. Am J Physiol 2002;283:L549-54.
23. Gaultier C. Malnutrition and lung growth. Pediatr Pulmonol 1991;10:278-86.
24. Wignarajah D, Cock ML, Pinkerton KE, Harding R. Influence of intrauterine growth restriction on airway development in fetal and postnatal sheep. Pediatr Res 2002;51:681-8.
25. Hoo AF, Henschen M, Dezateux C, Costeloe K, Stocks J. Respiratory function among preterm infants whose mothers smoked during pregnancy. Am J Respir Crit Care Med 1998;158:700-5.
26. Sekhon HS, Jia Y, Raab R, Kuryatov A, Pankow JF, Whitsett JA. Prenatal nicotine increases pulmonary a7 nicotine receptor expression and alters fetal lung development in monkeys. J Clin Investig 1999;103:637-47.
27. Elliot J, Vullermin P, Robinson P. Maternal cigarette smoking is associated with increased inner airway wall thickness in children who die of sudden infant death syndrome. Am J Respir Crit Care Med 1998;158:802-6.
28. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 1997;59:89-144.
29. Tulloh RMR, Hislop AA, Boels PJ, Deutsch J, Haworth SG. Chronic hypoxia inhibits postnatal maturation of porcine intrapulmonary artery relaxation. Am J Physiol 1997;272:H2436-45.
30. Fike CD, Kaplowitz MR, Thomas CJ, Nelin LD. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lungs. Am J Physiol 1998;274:L517-26.
31. Fike CD, Pfister SL, Kaplowitz MR, Madden JA. Cyclooxygenase contracting factors and altered pulmonary vascular responses in chronically hypoxic newborn pigs. J Appl Physiol 2002;92:67-74.
32. Chicoine LG, Avitia JW, Deen C, Nelin LD, Earley S, Walker BR. Developmental differences in pulmonary eNOS expression in response to chronic hypoxia in the rat. J Appl Physiol 2002;93:311-8.
33. Ozaki M, Kawashima S, Yamashita T, Ohashi Y, Rikitake Y, Inoue N et al. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium. Hypertension 2001;37:322-7.
34. Kourembanas S. Hypoxia and carbon monoxide in the vasculature. Antioxid Redox Signal 2002;4:291-9.
35. Noguchi Y, Hislop AA, Haworth SG. Influence of hypoxia on endothelin-1 binding sites in neonatal porcine pulmonary vasculature. Am J Physiol 1997;272:H669-78.
36. Perreault T, Berkenbosch JW, Barrington KJ, Decker ER, Wu C, Brock TA et al. TBC3711, an ET(A) receptor antagonist reduces neonatal hypoxia-induced pulmonary hypertension in piglets. Pediatr Res 2001;50:374-83.
37. Ivy DD, Yanagisawa M, Gariepy CE, Gebb SA, Colvin KL, McMurtry IF. Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. Am J Physiol 2002;282:L703-12.
38. Hjalmarson O, Sandberg K. Abnormal lung function in healthy preterm infants. Am J Respir Crit Care Med 2002;165:83-7.
39. Hislop AA, Haworth SG. Pulmonary vascular damage in the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990;9:152-61.
40. Chambers HM, van Velzen D. Ventilatory related pathology in the extremely immature lung. Pathology 1989;21:79-83.
41. Northway WH, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlock PT et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990;323:1793-9.
42. Sekhon HS, Thurlbeck WM. Lung morphometric changes after exposure to hypobaria and/or hypoxia and undernutrition. Respir Physiol 1996;106:99-107.
43. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol 2000;279:L600-07.
44. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol 2002;282:L811-23.
45. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;164:1971-80.
46. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol 2002;283:L555-62.
47. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc MG, Waltenberger J et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001;15:427-38.
48. Vicencio AG, Eickelberg O, Stankewich MC, Kashgarian M, Haddad GG. Regulation of TGF-beta ligand and receptor expression in neonatal rat lungs exposed to chronic hypoxia. J Appl Physiol 2002;93:1123-30.
49. Tang J-R, Le Cras TD, Morrish KG Jr, Abman SH. Brief perinatal hypoxia increases severity of pulmonary hypertension after reexposure to hypoxia in infant rats. Am J Physiol 2000;278:L356-64.